ondansetron and mianserin

ondansetron has been researched along with mianserin in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (25.00)18.2507
2000's4 (33.33)29.6817
2010's5 (41.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bryce, D; Chalabi, PM; Furman, J; Guarino, KJ; Ives, JL; McLean, S; Nagel, AA; Rosen, T; Roth, RW; Seeger, TF1
Topliss, JG; Yoshida, F1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Gozlan, H; Hamon, M; Kidd, FJ; Levy, JC; Nielsen, M1
Lauder, JM; Moiseiwitsch, JR1
Bhargava, VK; Saha, L1
Foley, KF; Kast, RE1
Bhatia, KS; Fowler, JC; Lee, TH; Szabo, ST; Wetsel, WC1
Arias, C; Spear, NE1
Koch, H; Nanev, D1
Lozano, R1

Other Studies

12 other study(ies) available for ondansetron and mianserin

ArticleYear
Synthesis, in vitro binding profile, and central nervous system penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazole.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:11

    Topics: Animals; Blood-Brain Barrier; Brain; Chemical Phenomena; Chemistry; Glioma; Imidazoles; Mice; Molecular Structure; Neuroblastoma; Serotonin Antagonists; Thiazoles; Tumor Cells, Cultured

1990
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.
    European journal of pharmacology, 1993, Sep-15, Volume: 247, Issue:1

    Topics: Aged; Aged, 80 and over; Animals; Benzamides; Binding Sites; Brain; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Female; Glioma; Hippocampus; Humans; Male; Mianserin; Ondansetron; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists; Spinal Cord; Stereoisomerism; Tissue Distribution; Tumor Cells, Cultured

1993
Regulation of gene expression in cultured embryonic mouse mandibular mesenchyme by serotonin antagonists.
    Anatomy and embryology, 1997, Volume: 195, Issue:1

    Topics: Aggrecans; Animals; Calcium-Binding Proteins; Chondroitin Sulfate Proteoglycans; Culture Techniques; Extracellular Matrix Proteins; Female; Gene Expression Regulation, Developmental; Lectins, C-Type; Mandible; Mesoderm; Mianserin; Mice; Mice, Inbred ICR; Nerve Growth Factors; Ondansetron; Piperazines; Pregnancy; Proteoglycans; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Serotonin Antagonists; Tenascin

1997
Serotonergic mechanism in imipramine induced antinociception in rat tail flick test.
    Indian journal of physiology and pharmacology, 2001, Volume: 45, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Animals; Fenclonine; Imipramine; Male; Mianserin; Ondansetron; Pain Measurement; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Antagonists

2001
Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects.
    European journal of cancer care, 2007, Volume: 16, Issue:4

    Topics: Antiemetics; Antineoplastic Agents; Benzodiazepines; Cachexia; Humans; Mianserin; Mirtazapine; Nausea; Neoplasms; Olanzapine; Ondansetron; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists

2007
Reversal of long-term methamphetamine sensitization by combination of pergolide with ondansetron or ketanserin, but not mirtazapine.
    Behavioural brain research, 2011, Sep-30, Volume: 223, Issue:1

    Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Infusion Pumps, Implantable; Ketanserin; Male; Methamphetamine; Mianserin; Mirtazapine; Ondansetron; Pergolide; Rats; Rats, Sprague-Dawley

2011
Mianserin, but not ondansetron, reduces the locomotor stimulating effect of ethanol in preweanling rats.
    Pharmacology, biochemistry, and behavior, 2011, Volume: 100, Issue:1

    Topics: Animals; Animals, Newborn; Dose-Response Relationship, Drug; Ethanol; Female; Male; Mianserin; Motor Activity; Ondansetron; Rats; Rats, Sprague-Dawley; Weaning

2011
Important interaction between mirtazapine and ondansetron.
    African journal of psychiatry, 2012, Volume: 15, Issue:3

    Topics: Aged; Antidepressive Agents, Tricyclic; Antiemetics; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Mianserin; Mirtazapine; Ondansetron

2012
Mirtazapine and ondansetron: a dual pharmacodynamic and pharmacokinetic interaction.
    African journal of psychiatry, 2013, Volume: 16, Issue:1

    Topics: Antidepressive Agents, Tricyclic; Antiemetics; Drug Interactions; Humans; Male; Mianserin; Ondansetron

2013